Text Size

Outpatient Cardiac Rehabilitation in Austria

This study is currently recruiting participants.
Verified February 2012 by Paracelsus Medical University
Sponsor:
Information provided by (Responsible Party):
Prof. Josef Niebauer M.D., Ph.D., MBA, Paracelsus Medical University
ClinicalTrials.gov Identifier:
NCT01540006
First received: February 22, 2012
Last updated: February 27, 2012
Last verified: February 2012
History of Changes
  Purpose

The aim of this prospective trial is the manifestation of guidelines developed for outpatient cardiac rehabilitation in Austria.

The evaluation of prospective and retrospective data is supposed to give evidence on morbidity and/or mortality advantages compared to patients not participating in cardiac rehabilitation programs.

The database created in this context is supposed to pave the way as instrument to document and comprehend quality and cost effectiveness of outpatient cardiac rehabilitation in Austria as a key for quality management.


Condition Intervention
Heart Disease
 Other: Physical activity

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Paracelsus Medical University:

Estimated Enrollment: 1000
Study Start Date: January 2009
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Physical activity
    50min of endurance training combined with 45min of calisthenics; 1-3x/week; 6-24 weeks
  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Any patients with heart disease willing to participate in an ambulant cardiac rehabilitation.

Criteria

Inclusion Criteria:

  • heart disease

Exclusion Criteria:

  • participation in another study within the previous 6 months
  • Medical conditions which prevent patients from complying with the exercise program
  • Acute infections
  • Hypertrophic cardiomyopathy
  • Pulmonary artery embolism or phlebothrombosis within the previous 6 months
  • Unstable angina pectoris
  • Heart failure (NYHA IV)
  • Hemodynamically unstable arrhythmia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01540006

Contacts
Contact: Prof. Josef Niebauer, MD, PhD, MBA 00436624482 ext 4270 j.niebauer@salk.at

Locations
Austria
Department of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University Recruiting
Salzburg, Austria, 5020
Contact: Prof. Josef Niebauer, MD, PhD, MBA     00436624482 ext 4270     j.niebauer@salk.at    
Sponsors and Collaborators
Paracelsus Medical University
Investigators
Study Chair: Prof. Josef Niebauer, MD, PhD, MBA Paracelsus Medical University
  More Information

Additional Information:
Paracelsus Medical University Salzburg, Austria  This link exits the ClinicalTrials.gov site
Department of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University Salzburg, Austria  This link exits the ClinicalTrials.gov site

Publications:

Responsible Party: Prof. Josef Niebauer M.D., Ph.D., MBA, Primar, Paracelsus Medical University
ClinicalTrials.gov Identifier: NCT01540006     History of Changes
Other Study ID Numbers: UISM-6
Study First Received: February 22, 2012
Last Updated: February 27, 2012
Health Authority: Austria: Ethikkommission

Additional relevant MeSH terms:
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013